REAL-WORLD EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS

被引:0
|
作者
Astigarraga Urkia, U. [1 ]
Lopez I Gomez, M. [2 ]
Pineiro, I. [1 ]
Ibarrola Paino, L. [1 ]
Sada Urmeneta, G. [1 ]
Mendizabal, J. [1 ]
Del Val Del Amo, N. [1 ]
Garrido Courel, L. [1 ]
Paniagua Zudaire, I. [1 ]
Horcada, L. [1 ]
Gutierrez, R. [1 ]
Fito-Manteca, C. [1 ]
机构
[1] Hosp Univ Navarra, Rheumatol, Pamplona, Spain
[2] Hosp Univ Arava, Rheumatol, Vitoria, Spain
关键词
Real-world evidence; Psoriatic arthritis; Spondyloarthritis;
D O I
10.1136/annrheumdis-2023-eular.6012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0973
引用
收藏
页码:1705 / 1706
页数:2
相关论文
共 50 条
  • [21] Secukinumab Retention and Effectiveness in Patients with Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: 5-year Final Results of a Prospective Real-world Study
    Kiltz, Uta
    Sfikakis, Petros
    Bounas, Andreas
    Gullick, Nicola
    Lespessailles, Eric
    Juergens, Jan Brandt
    Rashkov, Rasho
    Schulz, Barbara
    Bao, Weibin
    Jagiello, Piotr
    Gaffney, Karl
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4725 - 4727
  • [22] Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
    Manuel José Moreno-Ramos
    Carlos Sanchez-Piedra
    Olga Martínez-González
    Carlos Rodríguez-Lozano
    Carolina Pérez-Garcia
    Mercedes Freire
    Cristina Campos
    Rafael Cáliz-Caliz
    Jerusalem Calvo
    Juan María Blanco-Madrigal
    Ana Pérez-Gómez
    María José Moreno-Martínez
    Luis Linares
    Fernando Sánchez-Alonso
    Carlos Sastré
    Isabel Castrejón
    Rheumatology and Therapy, 2022, 9 : 1475 - 1476
  • [23] Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
    Pons, Marion
    Georgiadis, Stylianos
    Ostergaard, Mikkel
    Ahmadzay, Zohra Faizy
    Glintborg, Bente
    Heberg, Jette
    Christensen, Sara Nysom
    Rasmussen, Simon
    Loft, Anne Gitte
    Castrejon, Isabel
    Sanchez-Alonso, Fernando
    Iannone, Florenzo
    Nordstrom, Dan
    Hokkanen, Anna-Mari
    Ciurea, Adrian
    Nissen, Michael J.
    Zavada, Jakub
    Pavelka, Karel
    Rotar, Ziga
    Pirkmajer, Katja Perdan
    Michelsen, Brigitte
    Mielnik, Pawel
    Bernardes, Miguel
    Khmelinskii, Nikita
    Laas, Karin
    Vorobjov, Sigrid
    Codreanu, Catalin
    Macfarlane, Gary J.
    Jones, Gareth T.
    Gudbjornsson, Bjorn
    Palsson, Olafur
    Wallman, Johan K.
    van der Horst-bruinsma, Irene
    Onen, Fatos
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    JOINT BONE SPINE, 2025, 92 (03)
  • [24] SECUKINUMAB EFFECTIVENESS AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY IN THE REAL-WORLD SETTING
    Gaffney, Karl
    Gullick, Nicola
    Kiltz, Uta
    Sfikakis, Petros
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Perella, Chiara
    Pournara, Effie
    Schulz, Barbara
    Veit, Justyna
    RHEUMATOLOGY, 2021, 60 : 99 - +
  • [25] Efficacy and safety of secukinumab in Chinese patients with psoriatic arthritis: Evidence from a real-world study
    Zhang Xiaohui
    Chen Yuan
    Geng Yan
    Deng Xuerong
    Zhang Zhuoli
    中华医学杂志英文版, 2024, 137 (21)
  • [26] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [27] DRUG SURVIVAL OF SECUKINUMAB FOR PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING
    Valero, Marta
    Joven-Ibanez, Beatriz
    Martin, Maria
    Campos Esteban, Jose
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Perez Gomez, Ana
    Bachiller-Corral, Javier
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1862 - 1862
  • [28] SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: DRUG SURVIVAL IN REAL-WORLD SETTING AND RESPONSE FACTORS
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Martin, Maria
    Valero, Marta
    Bachiller-Corral, Javier
    Joven-Ibanez, Beatriz
    Perez Gomez, Ana
    Campos Esteban, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 887 - 887
  • [29] Efficacy and safety of secukinumab in Chinese patients with psoriatic arthritis: Evidence from a real-world study
    Zhang, Xiaohui
    Chen, Yuan
    Geng, Yan
    Deng, Xuerong
    Zhang, Zhuoli
    CHINESE MEDICAL JOURNAL, 2024, 137 (21) : 2618 - 2620
  • [30] Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
    Moskal, Mateusz
    Krawiec, Piotr
    Zareba, Wojciech
    Swierczek, Izabella
    Ratusznik, Jakub
    Raputa, Wiktor
    Zielinski, Maciej
    Batko, Krzysztof
    Huk, Mikita
    Batko, Bogdan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)